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Abstract
Background: Studying the stoichiometry and intracellular trafficking of the T cell antigen receptor (TCR) is pivotal
in understanding its mechanisms of activation. The abTCR includes the antigen-binding TCRab heterodimer as
well as the signal transducing CD3εg, CD3εδ and ζ2 subunits. Although the TCR-interacting molecule (TRIM) is also
part of the abTCR complex, it has not been included in most reports so far.
Results: We used the native antibody-based mobility shift (NAMOS) assay in a first dimension (1D) blue native
(BN)-PAGE and a 2D BN-/BN-PAGE to demonstrate that the stoichiometry of the digitonin-solublized TRIM-
containing abTCR is TCRabCD3ε2gδζ2TRIM2. Smaller abTCR complexes possess a TCRab CD3ε2gδζ2 stoichiometry.
Complexes of these sizes were detected in T cell lines as well as in primary human and mouse T cells. Stimulating
the abTCR with anti-CD3 antibodies, we demonstrate by confocal laser scanning microscopy that CD3ε colocalizes
with ζ and both are degraded upon prolonged stimulation, possibly within the lysosomal compartment. In
contrast, a substantial fraction of TRIM does not colocalize with ζ. Furthermore, TRIM neither moves to lysosomes
nor is degraded. Immunoprecipitation studies and BN-PAGE indicate that TRIM also associates with the gδTCR.
Conclusions: Small abTCR complexes have a TCRab CD3ε2gδζ2 stoichiometry; whereas those associated with one
TRIM dimer are TCRab CD3ε2gδζ2TRIM2. TRIM is differentially processed compared to CD3 and ζ subunits after
T cell activation and is not degraded. The gδTCR also associates with TRIM.
Background
T cells are classified as ab or gδ T cells depending on
the type of T cell receptor (TCR) that they express. The
gδTCR is expressed on gδ Tc e l l sa n di si n v o l v e di n
their development and activation. gδTCR ligands are lar-
gely undefined, but include protein and non-protein
substances [1,2]. The abTCR controls the development
and activation of ab T cells, and thus plays a critical
role in the adaptive immune system. Its ligands are
non-self peptides presented by major histocompatibility
complex molecules (MHC) on the surface of antigen
presenting cells (APC).
The abTCR consists of TCRab,C D 3 gε,C D 3 δε and ζζ
(CD2472) dimers that are non-covalently bound to one
another [3,4]. The heterodimeric TCRab contains vari-
able immunoglobulin (Ig) domains, which bind to
peptide/MHC-complexes. Furthermore, it possesses a
transmembrane (TM) region that mediates its associa-
tion with the CD3 subunits via potentially positively
charged amino acids [5-7]. Each CD3 subunit contains
an invariable extracellular part, a TM region carrying
potentially negatively charged amino acids and a cyto-
plasmic tail with several signal transduction motifs,
including an immunoreceptor tyrosine-based activation
motif (ITAM) [8]. The ζ chain contains only 9 extracel-
lular amino acids buried within the abTCR complex
[9,10], a TM region with a potentially negatively charged
amino acid that also binds to TCRab, and a cytoplasmic
tail with three ITAMs. Upon ligand binding to TCRab,
the CD3 subunits undergo a conformational change
[11-14] and the ITAMs within the CD3 cytoplasmic
tails and ζ-chains become phosphorylated by protein
tyrosine kinases of the Src-family. They subsequently
recruit SH2-domain containing intracellular signaling
and adapter molecules to the plasma membrane. Hence,
while the TCRab heterodimer is responsible for binding
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serve as signal transducing elements. The gδTCR is
composed of the same signal transducing elements
while carrying the antigen binding TCRgδ heterodimer.
In addition to the above molecules, the TCR complex
also includes the transmembrane adapter protein TRIM
(TCR-Interacting Molecule) [15-17]. The association of
TRIM with the abTCR is suggested by the following
observations: (i) TRIM co-purifies either with the endo-
genous abTCR [16,18] or individually expressed ζ [18]
under mild detergent conditions, (ii) TRIM co-caps with
CD3ε upon antibody-mediated TCR-crosslinking in ab T
cells [18] and (iii) overexpression of TRIM leads to
enhanced abTCR expression at the cell surface [18].
However, in contrast to CD3 and ζ, TRIM is not manda-
tory for abTCR assembly and surface expression [19-22].
TRIM is structurally similar to the ζ chain; it has a
short extracellular domain, a long cytoplasmic tail and is
a disulfide-linked homodimer. However, its cytoplasmic
tyrosine residues are not contained within typical ITAM
sequences, but rather within YxxM-motifs that might
mediate binding of the p85 subunit of PI3K [16]. TRIM
is phosphorylated upon TCR-stimulation by Src protein
tyrosine kinases [16] and, together with other trans-
membrane adapter proteins (e.g. SIT), modulates TCR-
mediated signals thereby regulating thymocyte develop-
ment [22,23]. The precise signaling function of TRIM
remains elusive, since the TRIM knock-out mouse did
not show any phenotype in the assays employed [22].
Using the native antibody-based mobility shift
(NAMOS) assay, we recently revealed the stoichiometry
of the basic abTCR complex extracted from T cell
membranes which is TCRab CD3ε2gδζ2 [24-27]. The
stoichiometry of the gδTCR is TCRgδ CD3ε2gδζ2
(human) and TCRgδ CD3ε2g2ζ2 (mouse) [28]. However,
in these studies we did not look for TRIM-containing
TCR complexes. Therefore, the present study was aimed
at deciphering the stoichiometry of TRIM-containing
TCRs. Furthermore, we analyzed the intracellular fate of
T R I Mu p o nT C R - s t i m u l a t i o ni nc o m p a r i s o nw i t ht h a t
of other components of the TCR complex.
Results
The abTCR forms two complexes, one of which
contains TRIM
The TCR complex of the TCRab CD3ε2gδζ2 stoichiome-
try resolves in BN-PAGE just below the f1 marker
[24-27]. We noticed that digitonin-purified human
TCRs often showed a second larger complex in BN-
PAGE [25]. To characterize this complex biochemically,
using digitonin we purified the abTCR from the
31.13scTCRb T cell line [25], which expresses a single
chain-tagged TCRb subunit (scTCRb)[ 1 1 ] .T h es c - t a g
binds nitrophenol (NP) with moderate and nitroiodo-
phenol (NIP) with high affinity [29]. By binding to NP-
coupled columns and subsequently eluting the bound
complexes with free NIP, we purified the scTCR in its
native form. After separation by BN-PAGE, the eluted
abTCR complexes were detected with an anti-ζ anti-
serum. Figure 1A, lane 1 shows that under these experi-
mental conditions two distinct abTCRs were detected.
Note that the abTCR from Jurkat cells showed the
Figure 1 The large abTCR complex contains TRIM. (A) The single chain-tagged TCR (scTCR) was purified from digitonin-lysed 31.13scTCRb
cells using NP-sepharose affinity columns and free NIP for elution (lane 1). Pervanadate-stimulated Jurkat cells were lysed in digitonin and
abTCRs purified with anti-phosphotyrosine antibodies followed by phenylphosphate elution (lane 2). Membranes from Jurkat cells were lysed in
digitonin (lane 3). TCRs were separated by BN-PAGE and immunoblotted against ζ. The marker protein was ferritin in its 24- and 48-meric forms
(f1: 440 kDa, f2: 880 kDa). (B) 31.13scTCRb (lanes 1 and 3) and Jurkat (lane 2) cell lysates were subjected to affinity purification on NP-sepharose
columns. The purified proteins were separated on a reducing SDS-PAGE; TRIM and ζ were detected by immunoblotting. (C) NP-purified scTCRs
were separated by 1D BN-PAGE and 2D non-reducing SDS-PAGE. Immunoblotting was done against scTCRb, TRIM and ζ.
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absence of the sc-tag (lanes 2 and 3). The larger com-
plex was stimulation-independent, since it was present
in pervanadate-stimulated (lane 2) as well as in unstimu-
lated (lane 3) Jurkat cells. The increase in molecular
weight for the larger complexes indicated an additional
mass of 50 to 100 kDa (not shown).
TRIM forms disulfide-linked dimers of 60 kDa and
noncovalently associates with the TCR [16,18]. To test
whether TRIM is associated with the scabTCR, we
lysed 31.13scTCRb or Jurkat cells in digitonin and affi-
nity-purified abTCR complexes with NP-sepharose. The
purified material was separated on a reducing SDS-
PAGE. TRIM and ζ were detected by Western blotting.
The untagged abT C Rf r o mJ u r k a tc e l l sd i dn o tb i n dt o
NP-sepharose and thus TRIM was not detected (lane 2);
however, both TRIM and ζ were purified from scTCR
lysates, (Figure 1B, lane 3), indicating that TRIM asso-
ciated to the scTCR. This is in line with the binding of
TRIM to abTCRs [16,18].
Next we tested whether TRIM was part of the larger
abTCR complex seen in BN-PAGE. To this end, the
two scTCR complexes in the BN-PAGE were further
separated by a second dimension non-reducing SDS-
PAGE and analysed by anti-TCRb and anti-ζ Western
blotting. This approach revealed that both small and
large abTCR-complexes contained TCRb and ζ (Figure
1C, upper and lower panel). The signal detected by anti-
TCRb was at 90 kDa and that detected by anti-ζ was at
35 kDa, corresponding to the TCRab and ζζ dimers,
respectively. Immunoblotting against TRIM revealed
that TRIM dimers of 50-60 kDa were solely present in
the larger abTCR complex. Thus, two abTCR com-
plexes exist in digitonin lysates, one with TRIM and one
without.
Stoichiometry of TRIM-containing abTCR complexes
The NAMOS assay can be used to assess stoichiome-
tries of multiprotein complexes [25,26]. When the
NAMOS assay was performed using anti-TRIM antibo-
dies, we found that part of the abTCR shifted once at
low antibody concentrations (Figure 2A, band a), indi-
cating one antibody bound to the abTCR. With high
amounts of anti-TRIM antibody, a second shift was gen-
erated (band b) that likely contains two anti-TRIM anti-
bodies. Therefore, two anti-TRIM binding sites and thus
two copies of the TRIM protein are present, indicating
that one TRIM homodimer [16] is a component of the
large abTCR complex.
Next, we modified the NAMOS-assay, using it in a
second dimension (2D) BN-PAGE to also assess the
amount of CD3ε within the complex. The presence of
two abTCR complexes precludes the use of the
NAMOS-assay in a 1D BN-PAGE, since both large and
small abTCR complexes would shift, resulting in several
bands, which would be difficult to assign. We separated
the two abTCRs by BN-PAGE, and subsequently let
antibody bind during a further separation by 2D BN-
PAGE. We tested various experimental conditions to
bring the antibody into contact with the complexes
inside the first dimension BN-PAGE (not shown). The
protocol that worked best was to load varying amounts
of antibody onto the 2D gel and allow it to enter the
stacking gel by brief electrophoresis. Subsequently, the
Figure 2 The stoichiometry of the TRIM-containing abTCR. (A) Digitonin-solubilized scTCRs from 31.13scTCRb cells were purified from NP-
sepharose affinity columns using free NIP for elution. Before loading on a native gel, the TCR was incubated with the indicated amounts of the
anti-TRIM antibody TRIM-7, and after separation, immunoblotted with anti-ζ. abTCR complexes bound to one or two antibodies are marked with
a or b, respectively. Ferritin was used as a marker protein as in figure 1. (B) abTCRs were purified as in (A) and after separation by a 1D BN-PAGE,
each lane was subjected to a 2D BN-PAGE into which the indicated amounts of the anti-CD3ε antibody UCHT1 had been loaded. The anti-ζ
antiserum was used for Western blot detection. Arrows: small, the TCRab CD3ε2gδζ2 TCR; and large, the TCRab CD3ε2gδζ2TRIM2 TCR.
(C) a schematic of the TRIM-containing large abTCR complex is shown.
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Page 3 of 101D gel slices containing the abTCR complexes were
placed over the 2D stacking gel and electrophoresis was
continued. When we applied this 2D BN-/BN-PAGE
NAMOS-assay to the abTCRs using an anti-CD3ε anti-
body, we detected two shifts for both complexes (Figure
2B), indicating that both contained two CD3ε subunits.
A third shift evident at 0.4 μg/μl anti-CD3ε is attributed
to two abTCR complexes crosslinked by one antibody,
a phenomenon occurring at non-saturating antibody
concentrations (Figure 2B, 3rd panel). The large abTCR
complex thus contains TCRab (Figure 1C), ζ2 (Figures 1
and 2), one TRIM homodimer (Figure 2A) and two
CD3ε (Figure 2B). Since CD3ε always pairs with CD3g
and CD3δ [ 3 ]i tc a nb ec o n c l u d e dt h a tt h eT R I M - c o n -
taining abTCR has a stoichiometry of TCRab
CD3ε2gδζ2TRIM2 (Figure 2C).
TRIM is loosely associated with the abTCR
We have observed the larger TRIM-containing abTCR
in BN-PAGE over many years. One example is shown in
f i g u r e3 ,w h e r ew eh a v eu s e dt h es c T C R( F i g u r e3 A ) .
Depending on the experiment, the proportion of TRIM-
containing abTCRs can vary from 50% of all abTCRs
(lane 1) to undetectable amounts (lane 4). The reasons
for this inconsistency might include: different lots of the
detergent digitonin used for abTCR extraction and
washing, different detergent/lipid ratios and slightly dif-
ferent purification and separation conditions. The large
TRIM-abTCR band has a defined size, indicating that it
contains a specific protein complex and is not an arte-
fact caused by protein aggregation. The observation that
TRIM is easily lost from the abTCR complex shows
that TRIM is loosely associated and that a large percen-
tage of abTCRs might contain TRIM in the living cell.
The TRIM-containing abTCR is present in primary T cells
To extend our studies to primary cells from human and
mouse, we used human peripheral blood T lymphocytes
as well as murine thymocytes (Figure 3B, lanes 2 and 3).
Jurkat cells served as a control (lane 1). Digitonin-solu-
bilized abTCR complexes were separated by BN-PAGE.
The larger abT C Rc o m p l e x ,t h a tm o s tl i k e l yi n c l u d e s
TRIM, was present in primary cells. This is in line with
our earlier data showing that TRIM co-caps with CD3
in primary human cells [18] and that TRIM is expressed
in murine thymocytes [30].
TRIM is also a component of the gδTCR complex
We are also interested in the gδTCR complex. We have
shown that the most abundant human gδTCR after digi-
tonin extraction has a stoichiometry of TCRgδ
CD3ε2gδζ2 [28]. To test whether a second larger com-
plex of the gδTCR is detected in BN-PAGE, we analyzed
digitonin-purified gδTCRs from the human gδ Tc e l l
l i n eP e e ro rf r o mah u m a ngδ T cell clone. Peer cells
express a gδTCR containing the TCRg2p r o t e i na n dt h e
clone a Vg9Vδ2 receptor (data not shown) including the
TCRg1 protein. Separated gδTCRs were detected by
Western blotting using anti-ζ antibodies (Figure 4A).
Under these experimental conditions two distinct
gδTCRs were detected. The size difference is likely due
to the incorporation of one TRIM dimer in the larger
complex. To confirm that TRIM binds the gδTCR, we
immunopurified the gδTCR from lysates of Peer gδ T
cells using anti-TCR specific antibodies. Complexes
were separated by non-reducing SDS-PAGE; TRIM and
ζ were detected by Western blotting (Figure 4B). In con-
trol samples, TRIM was absent in anti-TCRb precipi-
tates prepared from Peer cells (lane 3) and anti-TCRgδ
precipitates from Jurkat cells (lane 9). However, TRIM
was found in anti-CD3ε,a n t i - T C R gδ and anti-ζ
immuno-isolates of Peer cells (lanes 1, 2 and 5) as well
as anti-CD3ε,a n t i - T C R ab and anti-ζ immuno-isolates
of Jurkat T cells (lanes 7, 8 and 11). Thus, TRIM also
associates with the gδTCR, independent of which TCRg
chain is used.
Intracellular fate of TRIM after abTCR stimulation
Upon binding of peptide/MHC-complexes the abTCR is
endocytosed and degraded in lysosomes [31]. To assess
Figure 3 Primary cells express the TRIM-containing abTCR.( A )
31.13scTCRb cells were lysed with digitonin on different days using
different lots of digitonin. scTCRs were purified from NP-sepharose
affinity columns using free NIP for elution. TCRs were separated by
BN-PAGE and immunoblotted against ζ. (B) TCRs were purified from
pervanadate-stimulated Jurkat cells as in figure 1A (lane 1).
Membranes were prepared from human PBMC and lysed in
digitonin (lane 2). Murine thymocytes were stimulated with
pervanadate and and TCRs purified with anti-phosphotyrosine
antibodies followed by phenylphosphate elution (lane 3). TCRs were
separated by BN-PAGE and immunoblotted against ζ. Ferritin was
used as a marker protein as in figure 1.
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T-cell activation, we stimulated human peripheral blood
T lymphocytes with anti-CD3ε mAb and subsequently
investigated the subcellular localization of TRIM by
means of confocal laser scanning microscopy. As pre-
viously reported, TRIM showed strong capping at the T
cell surface after one hour of abTCR stimulation (Figure
5A, upper panel). Similarly, abTCR stimulation induced
capping of the ζ chain (lower panel).
To further assess the relationship between CD3ε, ζ
and TRIM after abTCR stimulation, we studied the
colocalization of ζ/CD3ε and ζ/TRIM in capped cells by
means of confocal laser scanning microscopy. Confirm-
ing the tight interaction between the two molecules
within the abTCR complex, ζ and CD3ε showed an
almost 100% co-localization after 1 hour of T cell acti-
vation (Figure 5B, left panel). In marked contrast, under
the same experimental conditions, we only observed a
partial colocalization between TRIM and ζ (right panel).
This finding suggested that the intracellular fate and
processing of TRIM differs from that of the other
abTCR components. This assumption was further sub-
stantiated by the finding that TRIM did not colocalize
with the lysosomal marker Lamp1 at early or late time
points of T cell activation (Figure 6A). Furthermore,
while the fluorescence signals for both CD3ε and ζ were
almost completely lost after prolonged stimulation (due
to lysosomal degradation), significant amounts of TRIM
Figure 4 TRIM is part of the gδTCR complex. (A) The human gδ T cell line Peer (left) and a human Vg9Vδ2 clone (right) were pervanadate-
stimulated and lysed in digitonin. gδTCRs were purified with anti-phosphotyrosine antibodies followed by phenylphosphate elution. TCRs were
separated by BN-PAGE and immunoblotted against ζ. Ferritin was used as a marker protein as in figure 1. (B) Peer gδ and Jurkat ab T cells were
lysed and immunoprecipitations performed with antibodies recognizing the indicated proteins (lanes 1 - 5 and 7 - 11). Purified proteins, as well
as lysates (lanes 6 and 12), were separated by non-reducing SDS-PAGE. TRIM and ζ were detected by immunoblotting.
Figure 5 Colocalization of TRIM with CD3ε and ζ 1 hour post-abTCR activation. (A) Human peripheral blood T cells were incubated with
the IgM anti-CD3ε mAb 2Ad2a2 for 1 hour or left unstimulated. Cells were fixed and the subcellular localization of TRIM and ζ was determined
using the antibodies TRIM-7 mAb (top) and anti-ζ mAb 6B10.2 (bottom). Secondary staining was done with a Texas red-labeled donkey anti-
mouse antiserum. (B) Cells were stimulated as in (A), then fixed and the subcellular localization of ζ detected using FITC-labelled anti-ζ mAb
6B10.2. CD3ε was visualized using Texas Red-labelled goat anti-mouse IgM (left) and a biotinylated TRIM-4 mAb followed by Texas Red-coupled
streptavidin were used to detect TRIM (right).
Swamy et al. Cell Communication and Signaling 2010, 8:5
http://www.biosignaling.com/content/8/1/5
Page 5 of 10were still detectable even after 18 hours of T cell activa-
tion (Figure 6B). Thus, despite its association with the
abTCR complex, upon T cell activation the intracellular
processing of TRIM differs from that of the other
abTCR components.
Discussion
The stoichiometry of the TCR complex has been exten-
sively studied [4]. However, the TRIM protein, known
to associate with the TCR, was not included in these
studies. Using the NAMOS assay [26], we show that in
digitonin two abTCR complexes exist with the
stoichiometries TCRab CD3ε2gδζ2 and TCRab
CD3ε2gδζ2TRIM2. Thus, two TRIM molecules associate
with some abTCR complexes. This is in line with the
dimeric nature of TRIM [16].
In digitonin detergent lysates, most abTCRs did not
i n c l u d eT R I M .O no n eh a n d ,t h i sc o u l di n d i c a t et h a t
most abTCRs lack TRIM on the cell surface. This is
possible, since TRIM is not required for surface expres-
sion of the abTCR [19-22], but still might be included
when present. On the other hand, TRIM might be part
of all abTCR complexes in T cells, but partially dissoci-
ates under our detergent conditions. The TCRab
Figure 6 Differential processing of TRIM compared to other abTCR complex components. (A) Human peripheral blood T cells were
incubated with anti-CD3ε mAb 2Ad2a2 to induce cap formation for 1 and 23 hours or left unstimulated. Cells were fixed and the subcellular
localization of TRIM detected using biotinylated TRIM-4 mAb and Texas Red-coupled streptavidin; LAMP1 was stained with FITC-labelled anti-
Lamp 1 antibody. (B) Cells were unstimulated (top) or stimulated as above for 18 hours. In all panels, actin was visualized using a Cy2-labelled
goat anti-rabbit antiserum. Primary mAb antibodies were: OKT3 for CD3ε; 6B10.2 for ζ; TRIM-7 for TRIM; and W6/32 for HLA-1. Texas Red-labelled
donkey anti-mouse was used as the secondary antibody.
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charged amino acids in the transmembrane regions of
its subunits [7]. TRIM does not have such amino acids
in its transmembrane region [16] and thus might associ-
a t el e s ss t a b l yw i t ht h er e s to ft h eabTCR. Indeed, our
data suggest that TRIM is loosely associated with the
abTCR and might be partially (or completely) lost upon
purification of the complex.
We have previously shown (and confirmed here) that
TRIM co-caps and co-modulates with the abTCR. Our
early studies demonstrated that the reduction of TRIM
expression in TCR-modulated T cells was less severe
than the reduction of CD3ε and ζ expression. Here, we
have extended these observations by showing that the
intracellular fate of TRIM differs from that of the other
abTCR components. Indeed, upon prolonged mAb-
mediated stimulation of ab T cells, CD3ε and ζ were no
longer detectable by microscopy, most likely due to
their degradation within the lysosomal compartment
[31-34]. Moreover, confocal laser scanning microscopy
revealed an almost complete colocalization of CD3ε and
ζ in capped T cells. In marked contrast, a substantial
fraction of TRIM did not colocalize with ζ in these cells.
Even after 18 hours of stimulation, a substantial fraction
of intracellular TRIM was still detectable within T cells
and thus was not degraded. These findings were further
corroborated by the observation that upon T cell activa-
tion TRIM is not targeted to lysosomes (as evidenced by
lack of colocalization with the lysosomal marker
Lamp1).
The CD3, ζ and TRIM molecules contain the YxxL/I
internalization signal [35] that might target proteins for
lysosomal degradation [31]. However, not all YxxL/I
containing proteins are degraded. In case of the abTCR
it was shown that the Casitas B-lineage lymphoma pro-
teins c-Cbl and Cbl-b (RING-type E3 ubiquitin ligases)
together with Cbl adaptor proteins Src-like adaptor pro-
tein SLAP and ζ-associated protein ZAP70, target inter-
nalized ζ chains to degradation by lysosomes [36-39].
Thus, they are involved in abTCR downmodulation by
inhibiting recycling of internalized abTCRs. LAPTM5, a
lysosomal protein, is also involved in this degradation
pathway, since it binds to ubiquitinylated ζ,b u tn o tt o
CD3ε,C D 3 g or CD3δ [34]. Our observation that TRIM
does not co-localize with ζ and is not degraded might
be because TRIM is not bound by SLAP, Cbl, ZAP70 or
LAPTM5. Indeed. TRIM does not contain any ITAM to
which ZAP70 binds.
The double leucine (LL) internalization motif in CD3g
and CD3δ, but not in ζ, CD3ε or TRIM, does not target
for degradation [32,40]. Thus, these signals cannot be
the reason for differential targeting of TRIM compared
to CD3 and ζ. However, the transmembrane regions,
containing sorting motifs in the case of CD3ε and ζ
[41,42], are not conserved between CD3/ζ and TRIM.
This region of CD3 and ζ is negatively charged, but neu-
tral in TRIM. Thus, this might be the reason for their
differential fates after internalization. In conclusion,
while TRIM is a component of large abTCR complexes
on the T cell surface, it is differentially processed after
T cell activation.
TRIM binds to the ζ subunit of the abTCR [18]. Since
the gδTCR also contains ζ,w et e s t e dw h e t h e rT R I M
might associate with the gδTCR and thereby give rise to
a second larger detectable gδTCR. This was indeed the
case as shown by co-immunopurifications and BN-
PAGE analysis. The small human gδTCR complex has a
stoichiometry of TCRgδ CD3ε2gδζ2 [2,28]; the larger
complex likely has a TCRgδ CD3ε2gδζ2TRIM2 stoichio-
metry. At the double negative stage of T cell develop-
ment, TRIM is already expressed together with the pre-
TCR [30], which also includes ζ. Therefore, it is likely
that TRIM also associates with the pre-TCR complex. It
remains to be seen whether TRIM processing in the
context of pre-TCR and gδTCR activation is similar to
that observed with the abTCR complex.
Finally, we present an extension of the NAMOS-assay
to 2D BN-/BN-PAGE. The multiprotein complexes of
interest are first separated by standard BN-PAGE. Then
an antibody to a certain subunit (X) is added and a 2D
BN-PAGE is applied. Thus, each individual complex is
separately shifted due to the binding of the antibody to
X in the second dimension. From the spot patterns of
the 2D gel, the number of X molecules per complex can
be deduced separately for each complex. Using this
method, we show that two CD3ε molecules are present
in both the small and the large abTCR complex. We
tested several protocols and determined how to best add
t h ea n t i b o d yo fi n t e r e s tt o the TCR complex present
within the 1D BN-PAGE (see Methods). A NAMOS-
assay 2D BN-/BN-PAGE extends the applicability of the
assay to include multiprotein complexes in which a pro-
tein exists in more than one complex.
Conclusions
Here we describe four main results: 1. A novel method
to study stoichiometries in 2D BN-/BN-PAGE, in order
to define stoichiometries of multiprotein complexes
even if they are present in a mixture; 2. The abTCR
complex is found in two forms: TCRab CD3ε2gδζ2-
TRIM2 and TCRab CD3ε2gδζ2,n o ti n c l u d i n gT R I M ;3 .
After stimulation, the abTCR complex is internalized.
CD3 subunits are then degraded in lysosomes, however,
TRIM is not subject to this trafficking route and
remains intact; 4. TRIM is also associated with the
gδTCR.
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Cells
Jurkat, Peer and 31.13scTCRb T cells were maintained
in RPMI 1640 (GIBCO BRL) medium supplemented
with 5% FCS, as previously described [25]. Peripheral
blood T lymphocytes were prepared by E-rosetting from
freshly drawn venous blood of healthy donors as
described elsewhere [43]. Mouse thymocytes were pre-
pared as described [44]. The human gδ T cell clone was
generated from blood as before [28] and was named
PF55. PF55 expresses a Vg9Vδ2 TCR (data not shown).
Antibodies
The following monoclonal and polyclonal antibodies
(Abs) were used for immunoprecipitation, confocal laser
scan microscopy, Western blotting, and indirect immu-
nofluorescence as indicated: HLA-I (W6/32, for flow
cytometry analysis and cap formation); anti-ζ monoclo-
nal antibody (mAb), clone 6B10.2 (Santa Cruz Biotech-
nology, Inc., for confocal laser scan analysis and
immunoprecipitation); CD3ε mAb OKT3 (for co-cap-
ping and flow cytometry analysis); CD3ε clone 2Ad2a2
(IgM; donated by Dr. E. Reinherz, Dana Farber Cancer
Center, Boston, MA, for modulation experiments). The
rabbit anti-ζ antiserum 448 has been described pre-
viously [45]. The anti-TRIM mouse mAb TRIM-7 has
also been previously described [18]. Affinity-purified
polyclonal anti-TRIM antiserum was prepared as
described elsewhere [16,18] and used at 5-10 μg/ml for
confocal laser scan analysis.
Cell lysates and protein purification
To purify the TCR for subsequent BN-PAGE or NAMOS
assays, 10
7 Jurkat or Peer T cells were incubated in 200
μM pervanadate (8.8 μl2 3m Ms o d i u mo r t h o v a n a d a t e
plus 1.2 μl3 0 %H 2O2) at 37°C for 5 min in 1 ml RPMI
medium to induce tyrosine phosphorylation of the TCR.
Cells were lysed in 1 ml lysis buffer (20 mM TrisHCl pH
8, 137 mM NaCl, 2 mM EDTA, 10% glycerol, 10 μg/ml
leupeptin, 10 μg/ml aprotinin, 1 mM PMSF, 500 μM
Na3VO4, 1 mM NaF and 1% digitonin). Phosphorylated
proteins were purified by incubation with 1 μgo ft h e
anti-phosphotyrosine Ab 4G10 (Upstate Biotechnology)
and 3 μl protein G-Sepharose (Pharmacia) for minimum
6 hours. The beads were washed twice in lysis buffer,
once in BN buffer (0.5 M 6-aminohexanoic acid, 12.5
mM NaCl, 10% glycerol, 2 mM EDTA, 0.5% digitonin, 20
mM BisTris pH7.0, 1 mM PMSF) and eluted in 100 μl
BN elution buffer (BN buffer including 50 mM phenyl-
phosphate and 1 unit alkaline phosphatase to depho-
sphorylate the receptor) for a minimum of 30 min on ice.
The scTCR was purified from cell lysates using NP
(3-nitro-4-hydroxy-phenylacetate)-conjugated Sepharose,
washed three times with BN buffer, and the scTCR eluted
in BN-buffer containing 0.5 mM free NIP (NIP-caproic
acid, Biosearch Technologies). The eluate was then
directly loaded onto a BN gel, or first incubated with Abs
against specific subunits, as detailed below.
Membranes were prepared as described [12]
For immunoprecipitation of ab or gδTCRs in figure 4,
Jurkat or Peer cells were lysed in 1 ml lysis buffer (as
above, but containing 0.5% Brij-96 instead of digitonin)
and purified by incubation with antibodies against CD3ε
(UCHT1, kind gift of Dr. P Beverley, The Edward Jenner
Institute for Vaccine Research, Compton, UK), gδTCR
(5A6. E9, Pierce Chemical Co.), TCRb (BV8, Pharmin-
gen), TRIM or ζ(448, described above) coupled to protein
G-Sepharose for 4 hours. Beads were washed 4 times
with lysis buffer, resuspended in non-reducing sample
buffer, boiled 5 min and loaded onto SDS-PAGE.
BN-PAGE, SDS-PAGE and immunoblotting
BN-PAGE gradient gels (4%-9%) were prepared using a
gradient mixer and the Protean II system from BioRad;
the stacking gel was 3.2% polyacrylamide. Gel composi-
tion, pouring procedure and running conditions have
been described [46-49]. In short, the loaded gels were
run at 4°C at 20 V overnight. For running BN-PAGE,
sample buffer was omitted, but samples in BN elution
buffer were carefully overlaid with blue cathode buffer
instead (15 mM BisTris pH7.0, 50 mM Tricine and
0.02% Coomassie blue G250). The marker protein was
ferritin in its 24-, 48- and 72 meric forms (f1: 440 kDa,
f 2 :8 8 0k D a ,f 3 :1 3 2 0k D a ,r e s p e c t i v e l y ) .W e s t e r nb l o t -
ting was done using PVDF membranes and a semi-dry
transfer system, at 18 V for 15 to 20 minutes, with
transfer buffer containing 0.1% SDS. SDS-PAGE was
performed using standard protocols. The membranes
were developed using the Abs mentioned above and sec-
ondary Abs were anti-rabbit IgG coupled to HRPO or
goat anti-mouse IgG HRPO from Southern Biotechnol-
ogy. Visualization was performed using the ECL system.
The NAMOS assay was done as described [26,27]. In
brief, the indicated amounts of Abs were added to the
samples (10 to 20 μl), mixed and incubated for 5-30
min on ice before loading them on BN-PAGE. MPC-
antibody conjugates migrate slower in native gels, such
that the shift directly reflects the number of Ab mole-
cules bound to the complex.
NAMOS (Native antibody-based mobility shift) assay in
the second dimension
Protein complexes are initially separated by a first dimen-
sion (1D) BN-PAGE. They are then brought into contact
with anti-subunit Abs while inside the gel. Finally, the
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by a second dimension (2D) BN-PAGE. We tested several
experimental procedures for the formation of supercom-
plexes. The most successful procedure was to load given
amounts of Ab in a small volume (e.g. 10 - 20 μl) into the
large pocket of the 2D stacking gel. Using the BioRad
minigel equipment, electrophoresis is carried out for a few
minutes at 100 V, in order to let the Ab enter 1 - 2 mm
into the stacking gel. Then the gel run is stopped and the
1D gel lane placed into the large pocket, after which the
gel run is continued. During the stacking process, the Ab
comes into contact with the protein complexes and forms
supercomplexes that are then separated by the 2D separat-
ing gel.
Co-capping Experiments
Resting peripheral blood T cells were washed twice with
RPMI (without FCS) and adjusted to 7× 10
6 cells/ml in
RPMI 1640. 10 μl of this suspension was pipetted onto
each reaction field of an adhesion slide (Bio-Rad Labora-
tories) and allowed to adhere for 10 min at room tem-
perature. Adherent cells were washed twice with RPMI
and the slide was blocked for 15 min with complete cul-
ture medium. Cap formation was subsequently induced
by incubating the cells for 15 min with 15 μl mAb solu-
tion (10 μg/ml in complete culture medium), followed
by two washes with RPMI 1640 (50 μl per field) and
cross-linking of the primary Abs with 15 μl Texas red-
labeled donkey anti-mouse antiserum (Dianova; diluted
1:50 vol/vol in culture medium) for 35 min at room
temperature in the dark. Capped cells were washed
twice with 50 μl PBS supplemented with 0.2% NaN3 and
then fixed for 3 min with cold methanol (stored at -20°
C). The methanol was removed and the cells were fixed
for an additional 5 s with ice-cold acetone. Fixed cells
were washed twice with PBS and blocked again for 10
min with PBS/1% BSA at room temperature. Subse-
quently, affinity-purified polyclonal Abs directed at
TRIM and CD3ε were added (15 μl per field, concentra-
tion 10 μg/ml) and incubated for 30 min at room tem-
perature in the dark. The Ab-labeled cells were then
washed once with PBS/BSA (40 μl per field) and three
times with PBS. 15 μl secondary Cy2-labeled donkey
anti-rabbit Ab (Dianova) were then added (1:125 vol/vol
in PBS/1% BSA) and incubated for 30 min at room tem-
perature in the dark. Cells were washed once with PBS/
BSA, three times with PBS, and finally at least 5 min
with distilled water. The slides were then covered with a
cover slip, which was fixed with Elvanol (Calbiochem)
for at least 16 h.
Slides were viewed on a Laser scan microscope (Ernst
Leitz GmbH) using 570 nm (red emission) and 508 nm
(green emission) filters, respectively. In general, the
magnification was 40×.
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